SEC-sourced researchBeta
TCRX
TScan Therapeutics, Inc.
Company comparison ↗
Data passport
- CIK
- 0001783328
- Exchange
- Nasdaq
- Business activity
- — · SIC 2836
- Financial inputs
- 6/6
- Filing date
- Oct 2, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 2,816,000.0000 | Mar 4, 2026 |
| December 2025 | 10,325,000.0000 | Mar 4, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 10,325,000.0000 | -129,766,000.0000 | -135,319,000.0000 | 228,789,000.0000 | 105,666,000.0000 | Mar 4, 2026 |
| December 2024 | 2,816,000.0000 | -127,499,000.0000 | -110,822,000.0000 | 371,118,000.0000 | 130,148,000.0000 | Mar 4, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $10.33M | December 2025 | Mar 4, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $2.82M | December 2024 | Mar 4, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$129.77M | December 2025 | Mar 4, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$135.32M | December 2025 | Mar 4, 2026 | 10-K |
| Total assetsAssets | $228.79M | December 2025 | Mar 4, 2026 | 10-K |
| Total liabilitiesLiabilities | $105.67M | December 2025 | Mar 4, 2026 | 10-K |
New filings
- 4TCRX · TScan Therapeutics, Inc.Oct 2, 2026 · Other
- 4TCRX · TScan Therapeutics, Inc.Oct 2, 2026 · Other
- 8-KTCRX · TScan Therapeutics, Inc.Sep 30, 2026 · Current event
- SCHEDULE 13GTCRX · TScan Therapeutics, Inc.Sep 25, 2026 · Other
- 8-KTCRX · TScan Therapeutics, Inc.Sep 11, 2026 · Current event
- 8-KTCRX · TScan Therapeutics, Inc.Sep 2, 2026 · Current event
- 10-KTCRX · TSCAN THERAPEUTICS, INC.Mar 4, 2026 · Annual